Bodhi Tree Biotechnology Inc. (BDTB)

Bodhi Tree Biotechnology Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Revenue	0.04	0.02	0.04
Revenue Growth	15.63%	-59.52%	-
Gross Profit	0.04	0.02	0.04
Selling, General & Admin	0.15	0.16	0.12
Operating Expenses	0.15	0.16	0.12
Operating Income	-0.11	-0.15	-0.07
Interest & Investment Income	0	0	-
Pretax Income	-0.11	-0.15	-0.07
Income Tax Expense	0	0	-
Net Income	-0.12	-0.15	-0.07
Net Income to Common	-0.12	-0.15	-0.07
Net Income Growth	-	-	-
Shares Outstanding (Basic)	25	25	13
Shares Outstanding (Diluted)	25	25	13
Shares Change	0.72%	99.01%	-
EPS (Basic)	-0.00	-0.01	-
EPS (Diluted)	-0.00	-0.01	-
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-310.18%	-868.34%	-177.01%
Profit Margin	-313.58%	-880.39%	-177.01%
EBIT	-0.11	-0.15	-0.07
EBIT Margin	-	-	-177.01%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 24, 2026

Data Sources Report a data error